Bayer Q3 Pharmaceuticals Sales €4.68B, Up 8%; EBITDA Before Special Items Up 24%
Share
Why It Matters
Bayer's medicine business sold more drugs and made more profit this quarter. Watch how much cash they have left to spend on new ideas.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.